apabetalone

Failed pivotal study? You can still have breakthrough therapy status — FDA signals to Resverlogix
Endpoints
Mon, 02/3/20 - 10:59 am
Resverlogix
breakthrough therapy
clinical trials
FDA
apabetalone
Resverlogix gets FDA input, redesigns kidney trial
BioPharma Dive
Fri, 02/24/17 - 11:35 am
Resverlogix
FDA
kidney dialysis
apabetalone